RE:RE:RE:RE:Catalysts for the stock .... Yes, fair point and at a high level I agree that the company is generating materially more revenue than say 9 months ago. That and more clarity on positive momentum and revenue growth into 2022.
But the company has also created more dilution as well, with the $1.20 / share offering and the warrants that went with it, plus the dilution (upon conversion) of the latest debt round, plus ESOP issuances that took place.
So to be truly "apples to apples", any comparison must be on a "per fully diluted share" basis, not just simply top line revenue.
To be clear, I agree the picture is much better than a year ago, but am struggling to understand how folks are doing the math to justify some of the much higher (eg: $2 / share) price projections here.
Appreciate your thoughts, thanks !
diamondhands wrote:
Broadly speaking I think his point is that the company has fundamentally advanced significantly relative to last year, and therefore if the company was priced fairly at any point between e.g. c$0.9 - 1.98 then it should be worth at least that amount now.
for a specific valuation you can just run your own model, but hey maybe I can build one for you and share it, but even some back of napkin numbers suggest that as the growth strategy continues to unfold the value should be much higher over time